Psychedelic Stocks

Athletes Share How Psychedelics Helped Them Overcome Life-Changing Injuries

A recent CNN report has highlighted how several athletes used psychedelics to overcome life-changing injuries and the myriad of mental-health challenges these injuries caused.

Canadian Daniel Carcillo began playing professional ice hockey after graduating high school and broke into the National Hockey League (NHL) by age 20. After a decade-long career that saw him play for the Los Angeles Kings, New York Rangers and Philadelphia Flyers, Carcillo was a two-time Stanley Cup winner on the cusp of a well-earned retirement.

However, he says, seven diagnosed concussions left him with headaches, anxiety, depression and “dementia-like” symptoms, rendering him suicidal. The retired hockey player says he also suffered from severe insomnia and disrupted sleep, spending nights awake and sleeping during the day.

Carcillo spent more than half a million dollars on prescription treatments and medications at brain centers, concussion centers and stroke rehabilitation centers but did not find any relief. He finally tried psilocybin in what he called a “last-ditch effort” and notes that he felt “the way he should” and had a zest for life for the first time in quite a long time.

A growing body of literature has connected various psychedelics with significant improvements in mental health, especially in patients suffering from conditions that are typically hard to treat. Harvard Health describes psychedelics as a class of drugs that can induce sensory perceptions and altered thoughts.

Some clinical studies have found that psilocybin, the main psychoactive agent in magic mushrooms, can produce significant and long-term changes in people with treatment-resistant major depressive disorder in only one or two doses.

Although most psychedelic research is still in preliminary stages, and researchers still don’t fully understand how psychedelics deliver their benefits, people are increasingly using drugs such as psilocybin (magic mushrooms), LSD and MDMA in place of traditional mental-health treatments.  However, experts say psychedelic use may be associated with potential risks, including heart rate abnormalities, high blood pressure and mental issues, such as psychosis.

NFL quarterback Aaron Rodgers is an outspoken supporter of the legalization of certain hallucinogenic drugs. He claims a psychedelic concoction called ayahuasca has helped boost his performance on the field. During last year’s Denver psychedelic conference, Rodgers said it was ironic how substances that could “expand your mind” are illegal, while more harmful substances have been “legal for centuries.”

Former boxing champion Mike Tyson has also spoken in favor of magic mushrooms, claiming they saved his life. Ultimate Fighting Championship (UFC) president Dana White noted in 2021 that the UFC would dive into researching the impact of psychedelic drug therapy on the brain health of its athletes.

As more companies such as atai Life Sciences N.V. (NASDAQ: ATAI) enter the psychedelic drug-development space, more is likely to be unveiled about how athletes and other groups of patients can benefit from different hallucinogenic compounds.

About PsychedelicNewsWire

PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicNewsWire.com

PsychedelicNewsWire is powered by IBN

Chris@PNW

Share
Published by
Chris@PNW

Recent Posts

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage

The company targets all current ketamine indications, including anesthesia and pain management. The U.S. is…

4 days ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network

The Kadima Neuropsychiatry Institute acquisition is part of NRx subsidiary HOPE Therapeutics’ model for a…

1 week ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval

Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with Universal Capital. Combined…

3 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition

Kadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network…

3 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Is ‘One to Watch’

NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting multibillion-dollar unmet needs in central…

4 weeks ago

Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform

Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is part of a rising wave of…

4 weeks ago